227 related articles for article (PubMed ID: 31605350)
61. Invited commentary.
Paul S
Ann Thorac Surg; 2015 Jan; 99(1):290-1. PubMed ID: 25555945
[No Abstract] [Full Text] [Related]
62. ASO Author Reflections: Endoscopic Ultrasonography for Determining Clinical T Classification for Esophageal Squamous Cell Carcinoma.
Yang HX; Yang J
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):956-957. PubMed ID: 30456674
[No Abstract] [Full Text] [Related]
63. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.
Ye B; Zhong CX; Yang Y; Fang WT; Mao T; Ji CY; Li ZG
World J Gastroenterol; 2016 May; 22(19):4750-6. PubMed ID: 27217706
[TBL] [Abstract][Full Text] [Related]
64. Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery.
Zhang D; Zheng Y; Wang Z; Huang Q; Cao X; Wang F; Liu S
Eur J Surg Oncol; 2017 Oct; 43(10):1949-1955. PubMed ID: 28716377
[TBL] [Abstract][Full Text] [Related]
65. ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.
Wong LY; Berry MF
Ann Surg Oncol; 2023 Apr; 30(4):2224-2225. PubMed ID: 36607525
[No Abstract] [Full Text] [Related]
66. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
67. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
68. Letter to the Editor: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Liu Z; Li Z
Ann Surg Oncol; 2021 Dec; 28(Suppl 3):837-838. PubMed ID: 33956274
[No Abstract] [Full Text] [Related]
69. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
70. Author's Reply: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(Suppl 3):839-840. PubMed ID: 33970373
[No Abstract] [Full Text] [Related]
71. Radical esophagectomy for a 92-year-old woman with granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.
Kitani M; Yamagata Y; Tanabe A; Yagi K; Aikou S; Kiyokawa T; Nishida M; Yamashita H; Mori K; Nomura S; Seto Y
World J Surg Oncol; 2016 Oct; 14(1):264. PubMed ID: 27737660
[TBL] [Abstract][Full Text] [Related]
72. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma.
Ma S; Yan T; Liu D; Wang K; Wang J; Song J; Wang T; He W; Bai J; Jin L; Chen X
Thorac Cancer; 2018 Feb; 9(2):310-315. PubMed ID: 29319236
[TBL] [Abstract][Full Text] [Related]
73. Very long-term outcomes of minimally invasive esophagectomy for esophageal squamous cell carcinoma.
Zhu Y; Chen W
J BUON; 2015; 20(6):1585-91. PubMed ID: 26854456
[TBL] [Abstract][Full Text] [Related]
74. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
76. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
77. Prognostic and predictive significance of tumor length in patients with esophageal squamous cell carcinoma undergoing radical resection.
Wu J; Chen QX
BMC Cancer; 2016 Jul; 16():394. PubMed ID: 27387460
[TBL] [Abstract][Full Text] [Related]
78. Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy.
Chen P; Han L; Wang C; Jia Y; Song Q; Wang J; Guan S; Tan B; Liu B; Jia W; Cui J; Zhou W; Cheng Y
Oncotarget; 2017 Jun; 8(25):41605-41619. PubMed ID: 28404928
[TBL] [Abstract][Full Text] [Related]
79. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
[TBL] [Abstract][Full Text] [Related]
80. Which factors are associated with extremely short-term survival after surgery in patients with esophageal squamous cell carcinoma?
Liu J; Wei Z; Zhang J; Hu W; Ma Z; Liu Q
Asia Pac J Clin Oncol; 2016 Sep; 12(3):308-13. PubMed ID: 27220635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
